Mek ICS Co

Mek ICS Co EBITDA per Share

The EBITDA per Share of Mek ICS Co (058110.KQ) as of Nov 4, 2026 is -519.84 KRW. In the previous year, EBITDA per Share was -1,660.53 KRW — a change of -68.69% (higher).

EBITDA per Share

-519.84KRW

YoY

-68.69%

Last updated:

EBITDA per Share of Mek ICS Co is 2025 -519.84 KRW. EBITDA per Share of Mek ICS Co was 2024 -1,660.53 KRW. It decreases by -68.69% higher compared to the previous year.

The Mek ICS Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-298.78 KRW
Jan 1, 2019
-3.11 KRW
Jan 1, 2020
5,721.93 KRW
Jan 1, 2021
2,069.19 KRW
Jan 1, 2022
-283.80 KRW
Jan 1, 2023
-2,525.30 KRW
Jan 1, 2024
-1,660.53 KRW
Jan 1, 2025
-519.84 KRW
The Mek ICS Co EBITDA per Share history
YEAREBITDA per ShareYoY
-519.84KRW-68.69%
-1,660.53KRW-34.24%
-2,525.30KRW+789.83%
-283.80KRW-113.72%
2,069.19KRW-63.84%
5,721.93KRW-184,196.83%
-3.11KRW-98.96%
-298.78KRW+94.40%
-153.69KRW-32.97%
-229.27KRW-146.89%
488.97KRW+629.80%
67.00KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mek ICS Co Stock analysis

What does Mek ICS Co do? MEKICS Co., Ltd. generates revenue through the manufacture and sale of specialized medical devices including artificial respirators for critical care and newborns, portable emergency respirators, high oxygen respirators, continuous positive pressure respirators, and patient monitors for vital sign monitoring. The company targets healthcare facilities such as hospitals and clinics that require advanced respiratory and patient monitoring solutions. Their product portfolio includes measuring appliances for oxygen saturation, which are sold alongside their primary respiratory equipment to meet comprehensive patient care needs in critical and emergency medical settings. The company's artificial respirators serve critical patient care and neonatal applications, while portable models support emergency response teams and mobile medical units. High oxygen and continuous positive pressure respirators address specific therapeutic requirements in intensive care environments. Patient monitors and oxygen saturation measuring appliances are essential for real-time patient assessment, creating recurring revenue streams through replacement parts and service contracts for these high-demand medical devices. MEKICS Co., Ltd. focuses on delivering integrated respiratory and monitoring solutions to healthcare providers across various medical specialties. Their product range caters to both acute care settings requiring immediate intervention and long-term patient management systems, ensuring consistent demand from hospitals and specialized medical facilities that prioritize advanced patient monitoring capabilities. Mek ICS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mek ICS Co stock

EBITDA per Share of Mek ICS Co is -519.84 KRW in 2025.

EBITDA per Share of Mek ICS Co changed from -1,660.53 KRW to -519.84 KRW, representing a -68.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Mek ICS Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Mek ICS Co

All Key Metrics — Mek ICS Co